Display options
Share it on

Data Brief. 2017 Jan 17;11:68-71. doi: 10.1016/j.dib.2017.01.007. eCollection 2017 Apr.

Data on gut metagenomes of the patients with .

Data in brief

Oksana E Glushchenko, Andrei E Samoilov, Evgenii I Olekhnovich, Boris A Kovarsky, Alexander V Tyakht, Alexander V Pavlenko, Vlad V Babenko, Andrei K Larin, Elena S Kostryukova, Maja V Malakhova, Elena N Ilina, Rustem A Abdulkhakov, Dilyara I Safina, Tatiana V Grigoryeva, Sayar R Abdulkhakov, Vadim M Govorun

Affiliations

  1. Federal Research and Clinical Centre of Physical-Chemical Medicine, Malaya Pirogovskaya 1a, Moscow 119435, Russia.
  2. Federal Research and Clinical Centre of Physical-Chemical Medicine, Malaya Pirogovskaya 1a, Moscow 119435, Russia; Moscow Institute of Physics and Technology, Institutskiy per. 9, Dolgoprudny, Moscow Region 141700, Russia.
  3. Kazan State Medical University, Butlerova 49, Kazan 420012, Russia.
  4. Kazan Federal University, Kremlyovskaya 18, Kazan 420008, Russia.
  5. Kazan State Medical University, Butlerova 49, Kazan 420012, Russia; Kazan Federal University, Kremlyovskaya 18, Kazan 420008, Russia.

PMID: 28138506 PMCID: PMC5256668 DOI: 10.1016/j.dib.2017.01.007

Abstract

Antibiotic therapy can lead to the disruption of gut microbiota community with possible negative outcomes for human health. One of the diseases for which the treatment scheme commonly included antibiotic intake is

Keywords: Antibiotic therapy; Gut microbiota; Helicobacter pylori; Metagenome

References

  1. Nat Commun. 2013;4:2469 - PubMed

Publication Types